3Bar Biologics
PrivateLast Round
Grant
Dec 7, 2022
Total Funding Raised
$3.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
3Bar Biologics operates in Healthcare & Life Sciences and is based in Columbus, Ohio. Its latest recorded funding round was a Grant round in December 2022.
3Bar Biologics is an agtech company that provides a proprietary delivery system for living microbes designed to improve the quantity and quality of crop production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Supply Chain, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
3Bar Biologics Comparables
Compare 3Bar Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kapsera | 71% | |
| IndoGulf BioAg | 69% | |
| Novonesis | 63% |
For institutional investors. Book with your work email.
3Bar Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 7, 2022 | ||||
| Seed | Nov 9, 2021 | ||||
| Grant | May 19, 2021 | ||||
| Seed | Aug 15, 2017 | ||||
| Accelerator | Aug 11, 2017 | ||||
Seed | Jul 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
3Bar Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SVG Ventures|THRIVE | Seed, Accelerator |
| QCA Ventures | Seed |
| QCA Ventures | Seed, Accelerator |
| Carmen Ventures | Seed, Accelerator |
| Rev1 Ventures | Seed, Accelerator |
| S2G Investments | Seed |
| Ohio TechAngel Funds | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 33% MoM, reaching 1K.
- May 1, 2025
Monthly visitors grew 221% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresAug 19, 2026
3Bar Biologics, Inc. appoints Chris Koenig as President in Ohio on Aug 13th '26 to lead day-to-day operations and execute its growth strategy.
For institutional investors. Book with your work email.
3Bar Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 3Bar Biologics's valuation, stock price, and market status.
Is 3Bar Biologics a public or private company?
3Bar Biologics is a private company.
What is the current stock price of 3Bar Biologics?
3Bar Biologics is a private company, so its shares have no public market price. Caplight tracks 3Bar Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 3Bar Biologics worth (valuation)?
Valuation information for 3Bar Biologics is not publicly available.
Can I buy 3Bar Biologics stock?
3Bar Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 3Bar Biologics's last funding round?
3Bar Biologics's most recent funding round was Grant on December 7, 2022.
Who are the main investors in 3Bar Biologics?
Key investors in 3Bar Biologics include Rev1 Ventures, S2G Investments.
Will 3Bar Biologics IPO soon?
No public IPO plans have been announced for 3Bar Biologics.
How can I track 3Bar Biologics secondary market activity?
Caplight tracks bids, offers, and trades in 3Bar Biologics's shares on secondary markets.